Fieldpoint Private Securities’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$163K Buy
6,000
+2,000
+50% +$58.5K 0.05% 283
2022
Q1
$146K Buy
4,000
+1,000
+33% +$36K 0.03% 364
2021
Q4
$148K Buy
3,000
+1,000
+50% +$55.5K 0.03% 368
2021
Q3
$142K Hold
2,000
0.03% 363
2021
Q2
$116K Hold
2,000
0.03% 388
2021
Q1
$50K Hold
2,000
0.01% 564
2020
Q4
$24K Buy
+2,000
New +$23.7K 0.01% 641
2020
Q1
Sell
-2,000
Closed -$32K 491
2019
Q4
$32K Hold
2,000
0.01% 497
2019
Q3
$16K Hold
2,000
0.01% 538
2019
Q2
$21K Hold
2,000
0.01% 521
2019
Q1
$24K Hold
2,000
0.01% 327
2018
Q4
$21K Hold
2,000
0.01% 327
2018
Q3
$26K Hold
2,000
0.01% 342
2018
Q2
$29K Hold
2,000
0.01% 335
2018
Q1
$73K Hold
2,000
0.03% 264
2017
Q4
$75K Sell
2,000
-500
-20% -$25.5K 0.04% 258
2017
Q3
$162K Buy
+2,500
New +$153K 0.07% 208
2017
Q2
Sell
-1,500
Closed -$84K 292
2017
Q1
$84K Buy
+1,500
New +$78.8K 0.07% 162

Other funds holding PRTA

Fieldpoint Private Securities's PRTA Position: Q2 2022 in Review

Fieldpoint Private Securities increased its Prothena Corp (PRTA) stake by 50% in Q2 2022, buying an estimated $58.5K and bringing the position to 6,000 shares worth $163K. The position accounts for 0.05% of the portfolio, ranked #283.

Fieldpoint Private Securities first reported a position in PRTA in Q1 2017 and has held it in 18 quarters since. 166 funds tracked by Wall St. Rank hold PRTA as of Q2 2022.

  • Fieldpoint Private Securities held 6,000 shares of Prothena Corp worth $163K as of Q2 2022.
  • Fieldpoint Private Securities bought 2,000 Prothena Corp shares in Q2 2022, an estimated $58.5K.
  • Prothena Corp made up 0.05% of Fieldpoint Private Securities's portfolio in Q2 2022, its #283 holding.
  • Fieldpoint Private Securities first reported a position in Prothena Corp in Q1 2017 and has held it in 18 quarters since.
  • 166 funds tracked by Wall St. Rank held Prothena Corp as of Q2 2022.

Based on Fieldpoint Private Securities's 13F filing for Q2 2022, filed 5 Aug 2022.